IGF-binding protein-5: Flexible player in the IGF system and effector on its own

Journal of Endocrinology

Volumn 172, Issue 3, 2002, Pages 423-440

  Schneider, M R ^a   Wolf, E ^a   Hoeflich, A ^a   Lahm, H ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

BONE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; KIDNEY FUNCTION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; REVIEW; SPECIES; STRUCTURE ANALYSIS; TUMOR CELL;

ANIMALS; BONE AND BONES; CELL NUCLEUS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KIDNEY; MALE; MAMMARY GLANDS, ANIMAL; MEMBRANE PROTEINS; MUSCLES; NEOPLASMS; OVARY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 0036126026     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1720423     Document Type: Review

References (210)

1. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration
2. Ovarian granulosa cell-derived insulin-like growth factor (IGF) binding proteins: Release of low molecular weight, high-affinity IGF-selective species
3. Ovarian granulosa cell-derived insulin-like growth factor binding proteins: Modulatory role of follicle-stimulating hormone
4. Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action. Evidence derived from the use of a truncated IGF-I analogue
5. A kinase-mediated regulation of granulosa cell-derived insulin-like growth factor binding proteins (IGFBPs): Disparate response sensitivities of distinct IGFBP species
6. The mouse intraovarian insulin-like growth factor I system: Departures from the rat paradigm
7. Altered expression of insulin-like growth factor-1 and insulin like growth factor binding proteins-2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity
8. Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5
9. Chicken insulin-like growth factor binding protein (IGFBP)-5: Conservation of IGFBP-5 structure and expression during evolution
10. Expression of growth hormone-releasing factor, growth hormone, insulin-like growth factor-1 and its binding proteins in human lung
11. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells
12. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor
13. A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells
14. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
15. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells
16. 1994 Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5
17. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin
18. Selective developmental regulation of gene expression for insulin-like growth factor-binding proteins in mouse spinal cord
19. Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle
20. Insulin-like growth factor binding protein-6: The 'forgotten' binding protein?
21. Anatomy of the pituitary insulin-like growth factor system
22. Synthesis and regulation of insulin-like growth factor binding protein-5 in FRTL-5 cells
23. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone
24. Ternary complexes containing insulin-like growth factor binding protein-5 (IGFBP) in normal and pregnancy serum
25. Phenotypic expression of IGF binding protein transcripts in muscle, in vitro and in vivo
26. IGFBP-5(201-218) stimulates Cdc42 GAP aggregation and filopodia formation in migrating mesangial cells
27. Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles
28. Expression of messenger ribonucleic acids of insulin-like growth factor binding protein-2, -4, and -5 in the ovine ovary: Localization and changes during growth and atresia of antral follicles
29. Correlation between insulin-like growth factor (IGF)-binding protein 5 and IGF-I gene expression during brain development
30. Progesterone stimulation of human insulin-like growth factor-binding protein-5 gene transcription in human osteoblasts is mediated by a CACCC sequence in the proximal promoter
31. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I
32. Localization studies of IGFBP-2 and IGFBP-5 in the anterior compartment of the eye
33. The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium
34. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion
35. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): Regulation by IGFBP-5-(201-218)
36. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3
37. Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation
38. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
39. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid
40. Insulin-like growth factor binding proteins and their role in controlling IGF actions
41. Posttranslational modification of the IGF binding proteins
42. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells
43. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells
44. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts
45. Phosphorylation of insulin-like growth factor binding proteins
46. Insulin-like growth factors I and II. Peptide, messenger ribonucleid acid and gene structures, serum, and tissue concentrations
47. The insulin-like growth factor-I receptor
48. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells
49. Insulin-like growth factor-binding protein (IGFBP)-5 in human testicular tubules
50. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression
51. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells
52. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells
53. Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway
54. Genetics of mouse growth
55. Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7
56. Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle
57. IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation
58. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5
59. Insulin-like growth factors (IGFs) stimulate and dexamethasone inhibits IGF binding protein (BP)-5 expression in a mouse pituitary cell line
60. Mutagenesis of basic amino acids in the carboxy-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding
61. Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland
62. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes
63. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs)-3, -5 and -6 inhibit IGFBP-4 degradation
64. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures
65. Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts
66. Gene expression of the insulin-like growth factor system during postnatal development of the rat pituitary gland
67. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development
68. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft
69. The role of growth factors in the suppression of active cell death in the prostate: An hypothesis
70. Insulin-like growth factor binding proteins are transcribed by preimplantation mouse embryos
71. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals
72. Retinoic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion
73. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas
74. IGF binding protein 5 and IGF-I receptor regulation in hypophysectomized rat kidneys
75. Regulation of insulin-like growth factor binding protein-5 mRNA abundance in rat intestinal smooth muscle
76. The insulin-like growth factor-binding protein (IGFBP) superfamily
77. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
78. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions
79. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation
80. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism
81. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
82. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblast by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences
83. Insulin-like growth factor binding protein-5 (IGFBP-5) binds to extracellular matrix and is phophorylated
84. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-1
85. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions
86. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity
87. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases
88. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
89. Molecular cloning of a new human insulin-like growth factor binding protein
90. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast
91. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: Biological and physiochemical characterization
92. Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone
93. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors
94. Identification of two clusters of mouse insulin-like growth factor binding protein genes on chromosomes 1 and 11
95. Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter
96. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum
97. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions
98. Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes
99. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells
100. Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: A comparison of normal and vasectomized patients
101. Altered IGFBP5 gene expression in the cerebellar external germinal layer of weaver mutant mice
102. Gene expression of the insulin-like growth factor system during mouse kidney development
103. Simultaneous detection of multiple gene expression in mouse and human individual preimplantation embryos
104. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): Analysis of IGFBP production by rat granulosa cells
105. Expression of insulin-like growth factor and binding protein genes during nephrogenesis
106. Transcriptional and post-translational regulation of insulin-like growth factor-binding protein-5 in rat articular chondrocytes
107. Differential effects of IGF-binding proteins, IGFBP-3 and IGFBP-5, on IGF-I action and binding to cell membranes of immortalized human chondrocytes
108. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors
109. Promoter-dependent and -independent activation of insulin-like growth factor binding protein-5 gene expression by prostaglandin E2 in primary rat osteoblasts
110. Insulin-like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation
111. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts
112. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3-kinase pathway
113. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
114. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice
115. Evidence that IGF-binding protein-5 functions as a growth factor
116. Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor-II
117. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action
118. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging
119. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
120. Insulin-like growth factor (IGF)-binding proteins in serum - Do they have additional roles besides modulating the endocrine IGF actions?
121. Expression of insulin-like growth factor binding protein-5 by ovine granulosa cells is regulated by cell density and programmed cell death in vitro
122. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein 5
123. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I
124. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I stimulated cell growth
125. Stimulatory effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells: The difference between transient and continuous treatments
126. Carboxyl-terminal parathyroid hormone fragments stimulate type-1 procollagen and insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells
127. Castration-induced apoptosis of androgen-dependent Shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins
128. Insulin-like growth factors in the regulation of avian ovarian functions
129. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme
130. PAPP-A2, a novel insulin-like growth factor binding protein-5 proteinase
131. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line
132. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5
133. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I
134. Transcriptional regulation of insulin-like growth factor-binding protein-5 by prostaglandin E2 in osteoblast cells
135. Differential IGF-independent effects of insulin-like growth factor-binding proteins (1-6) on apoptosis of breast epithelial cells
136. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria
137. Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age
138. Altered expression of insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat thyroid hyperplasia and involution
139. Insulin-like growth factor I (IGF-I) and long R(3)IGF-I differentially affect development and messenger ribonucleic acid abundance for IGF-binding proteins and type I receptors in in vitro produced bovine embryos
140. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney
141. Nuclear localization signal in insulin-like growth factor-binding protein type 3
142. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
143. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5
144. Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts
145. The phylogeny of the insulin-like growth factors
146. Characterization and hormonal regulation of a rat ovarian insulin-like growth factor binding protein-5 endopeptidase: An FSH-inducible granulosa cell-derived metalloprotease
147. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo
148. Insulin-like growth factor binding protein 5 and type-1 insulin-like growth factor receptor are differentially regulated during apoptosis in cerebellar granule cells
149. IGF-I and osteoporosis
150. Insulin-like growth factors and bone: The osteoporosis connection revisited
151. Insulin-like growth factors and bone: The osteoporosis connection
152. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation
153. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002
154. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins
155. Possible role of growth hormone, IGFs, and IGF-binding proteins in the regulation of ovarian function in large farm animals
156. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
157. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit
158. A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle
159. Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cells
160. 1-alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts
161. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
162. Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells
163. Gene expression of the six insulin-like growth factor binding proteins in the mouse conceptus during mid- and late gestation
164. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins
165. IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung
166. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells
167. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid
168. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human
169. Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5
170. Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5
171. Expression of insulin-like growth factor binding protein-4 and -5 mRNAs in adult rat forebrain
172. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation
173. Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors
174. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1 alpha in ovine articular chondrocytes
175. Insulin-like growth factor binding protein-5 proteolytic activity in ovine articular chondrocyte culture
176. Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats
177. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy
178. Characterization of insulin-like growth factor binding protein-5-degrading proteases produced throughout murine osteoblast differentiation
179. Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation
180. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat
181. Hormonal control of plasmin and tissue-type plasminogen activator activity in rat milk during involution of the mammary gland
182. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′,5′-monophosphate-dependent mechanism
183. The role of prolactin and growth hormone in the regulation of casein gene expression and mammary cell survival: Relationships to milk synthesis and secretion
184. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
185. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain
186. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit
187. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: Relationship to growth and glomerular filtration rate
188. Perinatal expression of IGFBPs in rat lung and its hormonal regulation in fetal lung explants
189. mRNA expression patterns of the IGF system during mouse limb bud development, determined by whole mount in situ hybridization
190. mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis
191. Cellular distribution of insulin-like growth factor binding protein mRNAs and peptides during rat lung development
192. Expression of mouse ovarian insulin growth factor system components during follicular development and atresia
193. Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis
194. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
195. Bovine oviductal and embryonic insulin-like growth factor binding proteins: Possible regulators of 'embryotrophic' insulin-like growth factor circuits
196. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork
197. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
198. Insulin-like growth factor I (IGF-I) regulates IGF binding protein-5 gene expression in the brain
199. Identification of an osteogenic protein-1 (bone morphogenetic protein-7)-responsive element in the promoter of the rat insulin-like growth factor-binding protein-5 gene
200. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms
201. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts
202. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein
203. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin
204. Anatomy of the human ovarian insulin-like growth factor system
205. Anatomy of the insulin-like growth factor system in the human testis
206. Insulin-like growth factor system gene expression in the human endometrium during the menstrual cycle
207. Cloning of the rat insulin-like growth factor binding protein-5 gene and DNA sequence analysis of its promoter region
208. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle
209. Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver
210. Local fetal signal is not required for maintaining IGFBP gene expression in the human decidua: Evidence from extrauterine pregnancies